TGFB1 and cranioectodermal dysplasia: For example, it is highly likely that administration of lumikine may enhance the expression of EGFR ligands by epithelial cells, which may then feed forward to activate the TGFβ-noncanonical Smad-independent signaling pathways for the healing of CED.